Intellectual Property Intellectual Property

Dry eye patent held invalid when viewed through proper lens

The claims of a Canadian patent are the numbered paragraphs at the end that define the scope of the legal exclusivity conferred by the patent. When...

Canada takes major steps toward enhanced biosimilar access

Over the last month, the Canadian Agency for Drugs and Technologies in Health and the Government of British Columbia have taken significant steps to...

When it comes to what you can patent, patent offices don’t always know best

In its decision in Cleveland Clinic, the U.S. Federal Circuit Court of Appeals invalidated an issued patent directed to a medical diagnostic method,...

Competition Bureau releases updated Intellectual Property Guidelines

On March 13, 2019, the Competition Bureau issued updated Intellectual Property Enforcement Guidelines, reflecting recent changes in the law and an...

Revised Abuse of Dominance Guidelines bring welcome and noteworthy guidance on numerous issues

On March 7, 2019, the Competition Bureau, under the direction of newly appointed Commissioner Boswell, released updated Abuse of Dominance...

CUSMA and regulatory amendments create challenges and opportunities for IP owners in 2018

There is perhaps no better illustration of the stunning rise in value of intellectual property (IP) assets than the recent trade negotiations between...

The first steps taken at the Canadian pharmaceutical patent dance

J Bradley White and Nathaniel Lipkus of Osler analyse the changes introduced by the amendments to the PMNOC Regulations.

A need-to-know guide on IP in the U.S.-Mexico-Canada Agreement

On October 1, 2018, the Government of Canada announced agreement on a deal for a modernized NAFTA, to be called the United States-Mexico-Canada...